Objective.
The clinical manifestations of Lyme disease have been and myalgia. This has led to 'overdiagnosis' of Lyme disease [3] [4] [5] . well documented since its first description as a distinct
In Europe, no clinical diagnostic criteria for Lyme entity in 1977 [1, 2] . In Europe, at least three distinct disease have been developed so far. Criteria developed species of Borrelia burgdorferi sensu lato can cause the in the USA by the Centers for Disease Control and clinical syndrome of Lyme disease: B. burgdorferi sensu Prevention (CDC ) for surveillance purposes are often stricto, B. garinii and B. afzelii. Clinical manifestations used as clinical criteria in the USA and in Europe. Since correlate with the genospecies causing the infection. The it is rather difficult to culture B. burgdorferi from speciclinical diagnosis of Lyme disease should be based on mens other than erythema migrans lesions, especially objective clinical signs and symptoms. Too often, the in daily clinical practice, the presence of antibodies to diagnosis is made in patients with non-specific and B. burgdorferi may confirm the clinical diagnosis. atypical features, such as headache, fatigue, arthralgia Although serological testing for Lyme disease can be performed with a high degree of sensitivity, falsenegative and false-positive results continue to be an
In these patients, a positive test can lead to 'overdiagnowith musculoskeletal complaints diagnosed as Lyme disease by our staff members. sis' and probably 'overtreatment'. False-positive results have been reported for patients with rheumatoid arthAll patients were seen by one of us (AAMB) who recorded a medical history and performed the physical ritis, systemic lupus erythematosus, infectious mononucleosis, syphilis and other spirochaetal diseases [7] . In examination. Questions were asked about past or recent tick exposure and the characteristic manifestations of Europe, asymptomatic seropositivity determined by enzyme-linked immunosorbent assay ( ELISA) and Lyme disease. Clinical records and former medical correspondence were studied. immunofluorescence assays (IFA) has also been demonstrated in up to 20% of the normal population as well
In the daily routine of our department, it is not possible to culture B. burgdorferi from clinical specias people at risk, such as orienteers, hunters and foresters [8] [9] [10] [11] . As a consequence, in the absence of typical mens. Genome amplification methods and urine antigen analysis are only used in experimental studies. of Lyme disease in The Netherlands exist. The incidence is assumed to be low and is estimated to vary from B. burgdorferi [17, 18] . Therefore, the clinical implications of this recommended two-step approach for the 0.01% in the general population to 2-9% in populations at risk and patients with monoarticular arthritis serodiagnosis of Lyme disease remain unclear and even questionable. [8, 10, 19] . In this clinical study, we studied a patient population Clinical criteria in which questions such as a true-or false-positive test result and active or previous infection are important.
On the basis of objective clinical signs and symptoms only, the patients were divided into three groups: previClinical criteria were used as a gold standard, and ELISA and immunoblot test results were used and ous Lyme disease, active Lyme disease and no Lyme disease. interpreted as in daily clinical practice. We have tried to assess whether immunoblotting should be performed in
The clinical criteria for Lyme disease according to literature references were defined as follows [6 ] : erythall patients with a positive ELISA and whether the suggested two-step approach can influence clinical ema migrans is defined as a red macula or papule that expanded over a period of days to weeks to form a large decision making.
annular lesion, at least 5 cm in size, often with partial central clearing [1, 20, 21] . Lyme arthritis is defined as recurrent, brief attacks of objective joint swelling in one practitioners. Because of our special interest in clinical Lyme disease, the department serves as a secondary or or a few joints, especially the knees, possibly followed by chronic synovitis [26 ] . Lyme carditis is characterized tertiary referral centre for patients with presumable Lyme disease or for patients with persisting complaints by fluctuating degrees of atrioventricular nodal block that resolved in days to weeks, possibly associated with thought to be chronic Lyme disease.
Patients eligible for this study were (i) patients with myocarditis [27] . Uveitis is defined as intermediate uveitis with characteristic spider web vitritis confirmed persisting musculoskeletal complaints assumed by their referring physicians to be attributable to active or by an ophthalmologist [28] . Acrodermatitis chronica atrophicans (ACA) is the characteristic bluish-red chronic Lyme disease, (ii) patients who believed that they had active or chronic Lyme disease and (iii) patients discolouration, often with a doughy infiltration and progressing to atrophy or sclerodermic changes [21] . late Lyme disease; the specificity of IgG immunoblot is 98% (unpublished data, personal communication). The Borrelial lymphocytoma is the typical bluish-red tumour-like infiltrate [21] . For all patients with neurocontrol population in which IgG immunoblot was tested consisted of healthy donors, pregnant women and potenlogical, cardiac, eye or joint abnormalities, all other possible causes of the complaints had to be excluded.
tially cross-reactive sera of patients with syphilis, leptospirosis or autoimmune diseases. The clinical diagnosis Skin lesions that developed immediately after a tick bite were not considered to be erythema migrans. Aspecific defined by a clinical expert was considered as the 'gold standard'. symptoms such as fatigue and arthralgia, fever, headache and paraesthesiae as a single symptom, palpitations, In our hospital, the clinician receives the results of immunoblotting interpreted by the laboratory as either bundle branch block on electrocardiography, myocarditis and symmetrical polyarthritis were not accepted as positive, negative or equivocal. Table 1) . Forty-seven of the 103 patients (46%) had IgG antibodtination assay was performed to exclude false positivity due to antibodies to T. pallidum.
ies to B. burgdorferi according to the ELISA at study entry: 25 patients with previous Lyme disease (51%), all Patients were tested at the time they were seen in our out-patient clinic. Because of our special patient popula-10 patients with active Lyme disease (100%) and 12 patients (27%) with no Lyme disease ( Table 1) . Results tion, it is possible that patients are seen not only if they have active symptoms of Lyme disease but also years are summarized in Of the 25 patients with antibodies to B. burgdorferi, 15 had had early symptoms of Lyme disease defined as was performed as described in the literature [16, 30] . The IgG immunoblot was considered positive if at least signs or symptoms within <1 yr after possible exposure. Fourteen of these patients had erythema migrans and five of the following eight bands were present: 17 kDa, 22 kDa, 31 kDa, 34 kDa, 39 kDa, 41 kDa, 58-74 kDa one patient had neuroborreliosis. Ten patients had late symptoms defined as signs and symptoms >1 yr after and 92 kDa, or if four bands were positive including 17 kDa or 22 kDa or 39 kDa or 92 kDa. One or more possible exposure. Two of these 10 patients had ACA, one had uveitis and seven had mono-or oligoarthritis bands in the 58-74 kDa region were considered as one band [31, 32] . IgG immunoblot was considered negative of the knees (six patients) and elbow (one patient).
Of the 24 patients without antibodies to B. burgdorferi, if three bands were positive excluding 17 kDa, 22 kDa, 39 kDa or 92 kDa, and if less than three bands were 19 had erythema migrans, one had erythema migrans and neuroborreliosis, and three had neuroborreliosis. found to be positive. IgG immunoblot was considered equivocal if four positive bands (31 kDa, 34 kDa, One patient had late symptoms: arthritis of the knee. Patients with antibodies to B. burgdorferi were seen 41 kDa and 58-74 kDa) were found, or only three bands including 17 kDa or 22 kDa or 39 kDa or 92 kDa. Using on average 3.9 yr after the diagnosis of Lyme disease was made elsewhere, patients without antibodies on the above criteria, the sensitivity of IgG immunoblot is 45% in early Lyme disease and 95% in disseminated or average after 4.6 yr. At study entry, none of these 49 T these patients are discussed briefly. A 37-yr-old male had systemic sclerosis and arthralgia. Because of anticlassified as previous Lyme disease, 18 had a positive immunoblot (72%) and seven had a negative immunobodies to B. burgdorferi, he was treated with several courses of ceftriaxone i.v. without any clinical effect. A blot. The seven patients with a negative immunoblot did have objective signs and symptoms of Lyme disease in 40-yr-old male had symmetrical, rheumatoid factor-negative polyarthritis. Treatment with doxycycline and of Lyme disease. No generally accepted criteria have been developed, although 'practice parameters' and ceftriaxone had no effect. He was started on sulphasalazine as a second-line anti-rheumatic drug with excellent guidelines for the diagnosis of patients with Lyme borreliosis of the nervous system and Lyme arthritis response. A 72-yr-old male had symmetrical, rheumatoid factor-positive, erosive polyarthritis classified as typical have been proposed and developed [22, 35] . Overdiagnosis as well as underdiagnosis of erythema rheumatoid arthritis. A 56-yr-old male had eczema and arthralgia. He never had objective signs of arthritis.
migrans, considered as the hallmark of the disease, have been described [36, 37] . For this particular study, we A 17-yr-old male was referred because of a tick bite in the past and antibodies to B. burgdorferi. He did not used diagnostic criteria based on the literature as well as our own experience with Lyme disease patients [2, 3, have any complaints or objective signs or symptoms. A 52-yr-old female had arthralgia without objective 5, 12, 13, 21, 22] . We grouped our patients on the basis of these clinical criteria independently of the serological arthritis. A 23-yr-old female had arthralgia and painful knees without signs of arthritis, classified as chondroresults, in an attempt to identify the possible surplus value of serology and immunoblotting. Patients could malacia patellae.
The positive results of ELISA and immunoblot in easily be assigned to one of the three groups previous Lyme disease, active Lyme disease and no Lyme disease. these seven patients have to be considered as true, but asymptomatic, positive. On clinical criteria, we do not Second, our study was performed in a referral hospital with a population of patients which is not representative feel that these patients have or had Lyme disease.
of the total population of patients with disease due to infection with B. burgdorferi. However, these patients Discussion are a reflection of the problems which are encountered in the daily management of patients with (presumed ) In this study, we evaluated recommendations for the use of a two-test approach for Lyme disease in a Lyme disease: active infection, past infection with persistent antibodies to B. burgdorferi, false-positive or clinical situation. We especially assessed whether clinical decision making was influenced by the suggested asymptomatic IgG antibodies to B. burgdorferi. We have not provided any data on sensitivity, specificity, and the two-test approach: a positive or undetermined ELISA should be followed by Western blot. The results indipositive or negative predictive values of the ELISA and immunoblotting, because these data would only be cate that immunoblotting does not reliably discriminate between previous infection and active infection with B.
applicable to a similar population and cannot be generalized for other populations. We used a standard commerburgdorferi. Clinical decision making was not influenced by the results.
cial ELISA for this study as will be used in daily clinical practice by most physicians. We are aware that more Twelve out of 44 patients classified as no Lyme disease at study entry had IgG antibodies to B. burgdorferi. sensitive assays will be available in the future. However, the possible surplus value of all these assays should be This percentage is in contrast with the percentage of antibodies to B. burgdorferi found in the Dutch populaevaluated against clinical criteria. Third, based on clinical criteria, we classified 44 tion and patients at risk [8, 10, 11] . This high percentage is probably due to referral bias. It is likely that patients patients as no Lyme disease. We used only objective signs and symptoms in our criteria. None of these 44 with antibodies are referred, as patients without antibodies are not. Seven of these 12 patients did have a positive patients ever had any of these symptoms. This would have made their pre-test likelihood of Lyme disease immunoblot. Based on their medical history and the clinical picture, these patients had not had Lyme disease.
<20%. These patients should not have been tested for the presence of antibodies to B. burgdorferi in the first In this group of patients classified as no Lyme disease, the use of immunoblotting could have added additional place because a positive test is more likely to be clinically false positive than true positive [10, 13]. We assumed information for the five patients whose immunoblot was negative. However, based on clinical criteria, these that it is likely that referring physicians use a negative result of ELISA for antibodies to B. burgdorferi to rule patients did not have Lyme disease at study entry or in the past. Thus, in this group of patients with no Lyme out the presence of Lyme disease and refer patients with a positive test result to our out-patient clinic. disease, the immunoblot did not influence clinical decision making either. Our study supports and Fourth, we studied a relatively small patient population with either positive or negative ELISA results. strengthens the suggestion that the diagnosis of Lyme disease should be made primarily on clinical signs and Larger study populations are needed for definite conclusions and for patients with possible indeterminate symptoms [33] . Neither the results of serological testing nor the results of immunoblotting can be interpreted ELISA results. However, it can be expected that if clinicians determine the pre-test probability of Lyme adequately without knowledge of clinical manifestations. Our results confirm the findings of Gern et al. [34] who disease in the diagnostic evaluation of a patient for Lyme disease, based on findings of a thorough clinical stated that immunoblotting is of little help in diagnosing Lyme disease in populations at risk as well as in endemic examination and knowledge of the incidence of Lyme disease in the population represented by the patient, areas where seropositivity for B. burgdorferi is common.
A few points should be stressed. 
